Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
JASINT 1
Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
80
Ans
Genre
Tous
Aire thérapeutique :
Oncologie
Maladie :
Carcinome urothélial
Traitement :
Vinflunine (Javlor®)
Phase :
Phase II
Date de début de l'étude :
05 Octobre 2010
End date :
22 Novembre 2010
Identifiant de l'essai :
L00070 IN 213 PI
Identifiant EudraCT/CTIS :
2010-020620-22
Envoyer par email